This test is most useful if any of these apply to you.
Birch pollen allergy is one of the most common seasonal allergies in temperate regions, and modern testing can break the pollen down into individual proteins to see exactly which ones your immune system reacts to. This test looks at one of those proteins, called Bet v 6 (an isoflavone reductase-like protein from silver birch).
Bet v 6 is a minor birch component. Most birch-allergic people react to a different protein called Bet v 1, while reactions to Bet v 6 are rare. This test is an exploratory tool that can fill in your immune profile when standard birch testing leaves questions unanswered.
This test measures IgE (immunoglobulin E) antibodies in your blood that specifically recognize the Bet v 6 protein from silver birch. IgE is the antibody class your immune system produces when it becomes sensitized to an allergen. When IgE binds to its target, it can trigger immune cells (mast cells and basophils) to release the chemicals responsible for allergy symptoms like sneezing, itching, and swelling.
A positive result means your immune system has built antibodies against Bet v 6. That is called sensitization. Sensitization is not the same thing as a clinical allergy. Some people have detectable IgE without ever having symptoms, while others with low IgE can still react. The level of antibody alone does not perfectly predict how strongly you will react in real life.
Birch pollen contains several proteins that can trigger an immune response. Bet v 1 is the major allergen and accounts for the vast majority of birch sensitization. Bet v 2 (a profilin) is a minor allergen often linked to broader pollen cross-reactivity. Bet v 6 sits at the rare end of the spectrum.
In a study of birch-allergic patients in northern China, only a very small fraction tested positive for Bet v 6 IgE, even though most had high levels of antibodies to the major birch protein. The researchers concluded that Bet v 6 sensitization rates are very low and that this component does not offer significant diagnostic value in that population. That makes Bet v 6 a low-frequency finding rather than a routine marker of birch allergy.
| Birch Component | How Often It Is Positive | What It Tells You |
|---|---|---|
| Bet v 1 | The large majority of birch-allergic people | Main marker of true birch allergy |
| Bet v 2 | A minority of birch-allergic people | Suggests broader cross-reactivity with other pollens |
| Bet v 6 | A small minority of birch-allergic people | Rare finding with uncertain clinical meaning |
Source: Wang et al., 2023, Journal of Asthma and Allergy.
What this means for you: if your Bet v 6 result is positive, you are in a small minority of birch-sensitized individuals. The presence of these antibodies alone does not confirm a clinical allergy, and the result should be read alongside symptoms and other birch component tests.
Bet v 6 is described as an isoflavone reductase-like protein, a category of molecules that exists in many plants. Because of this shared structure, Bet v 6 has been proposed as a potential cross-reactive allergen with certain plant foods. However, this cross-reactivity has not been clearly demonstrated in human studies. In the northern China cohort, Bet v 6-positive patients had multiple seasonal pollen allergies but no clear pattern of food allergy symptoms tied to this component.
In practice, a positive Bet v 6 IgE result raises the possibility that your immune system recognizes a less common birch protein and may potentially react to structurally similar proteins in foods or other plants. The strength of that signal, and whether it translates into symptoms, varies from person to person.
Birch pollen sensitization in general (most often measured through Bet v 1 rather than Bet v 6) is connected to several allergic conditions. The same conditions apply to anyone who is birch-sensitized, regardless of which specific component drives that sensitization.
Allergen-specific IgE results can shift over time. Levels respond to pollen season exposure, treatment with allergen immunotherapy, and natural changes in immune reactivity as you age. A large serum IgE study found that allergen-specific IgE levels tend to decline with age, which can in turn reduce the severity of allergic rhinitis symptoms.
A single test gives you a snapshot. If you are trying to understand your birch allergy or track whether an intervention like immunotherapy is changing your immune response, get a baseline now, retest in 3 to 6 months if you are making changes, and then at least annually to watch the trend. The pattern over time is more informative than any single number.
Pollen extract IgE tests can be tripped up by cross-reactive carbohydrate determinants (sugar tags present on many plant proteins) and by panallergens like profilins. A meaningful share of pollen-sensitized patients have IgE to these shared structures, which puts them at risk of being misdiagnosed if only crude extracts are used. Component tests like Bet v 6 are designed to cut through this noise, but they can still produce positive results without clinical significance.
A positive Bet v 6 result without matching symptoms usually means sensitization, not active allergy. A negative result does not rule out birch allergy, since most birch-allergic people react to Bet v 1 instead. The Bet v 6 number should always be read in the context of your symptom history and other birch component results.
If your Bet v 6 IgE is positive, the next step is rarely to act on this number alone. The most useful follow-up is to look at the rest of your birch profile: Bet v 1 (the major component), Bet v 2 (profilin), and other relevant tree pollens. If you have oral symptoms with certain raw fruits or nuts, food component tests like Mal d 1 (apple) or Cor a 1 (hazelnut) can refine the picture.
If you have respiratory symptoms during pollen season, an allergist can correlate your component results with skin testing and your symptom calendar. Sensitization without symptoms generally does not require treatment. Sensitization plus symptoms, especially severe or interfering with daily life, is where conversations about allergen immunotherapy and other targeted treatments belong.
Because Bet v 6 sensitization is rare and its clinical significance is still being studied, getting a baseline and trending it gives you data you can use as the science matures. If you start birch allergen immunotherapy or another treatment, retesting can help confirm whether your immune profile is shifting. If you have an unexplained reaction to a plant food, a recent Bet v 6 result may help your allergist consider less common cross-reactivities.
Silver Birch (Bet v 6) IgE is best interpreted alongside these tests.